Twist Bioscience Cash Flow Statement (2017-2026) | TWST

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-41.24M-45.56M-60.67M-60.52M-51.13M-41.82M-59.18M-57.40M-46.29M-42.99M-45.45M-85.57M-34.66M-31.60M-39.33M20.38M-27.10M-30.51M-44.02M-35.05M
Depreciation and Depletion (Quarter)
3.90M5.70M6.90M7.30M6.90M7.00M7.00M6.40M6.10M6.10M5.80M5.70M5.90M6.10M6.50M
Share-based Compensation (Quarter)
10.42M66.70M-16.51M-39.25M-2.33M6.42M0.12M2.46M11.02M13.82M13.73M-38.58M11.99M20.33M48.38M-48.38M24.77M18.94M18.18M
Deferred Taxes (Quarter)
10.54M0.50M0.13M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
2.19M1.17M0.43M0.98M17.53M0.25M0.33M0.45M1.53M0.25M0.26M0.14M0.29M
Cash from Operations (Quarter)
-34.80M-46.65M-42.34M-34.12M-1.27M-54.07M-44.29M-23.41M-20.70M-22.97M-19.42M-6.38M-15.32M-21.43M-12.99M-1.40M-11.81M-24.81M-17.56M1.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.03M-0.32M-0.47M13.86M1.17M
Depreciation & Amortization (CF) (Quarter)
2.43M3.15M3.97M4.44M4.95M5.29M7.03M8.49M8.50M8.17M8.30M8.30M6.66M6.38M6.40M6.07M6.00M6.19M6.41M6.78M
Change in Working Capital
Change in Receivables (Quarter)
0.29M2.03M1.81M6.44M-0.66M4.10M3.95M-5.54M1.81M-8.06M0.66M-4.00M2.95M4.54M10.72M-0.09M7.21M-6.83M14.24M1.08M
Change in Inventory (Quarter)
10.57M8.44M4.35M-1.55M-3.70M5.28M-4.67M-3.56M-4.29M-1.20M-0.49M-1.89M-4.41M-0.56M-2.66M5.08M2.37M4.62M0.59M1.65M
Change in Account Payables (Quarter)
3.35M-0.01M-0.76M1.23M6.92M3.28M-7.49M-0.22M1.92M-4.21M-1.52M-1.20M-4.88M5.71M0.71M3.19M-0.28M1.47M0.07M3.04M
Change in Accured Expenses (Quarter)
1.57M-0.03M0.87M2.12M1.90M-1.25M4.15M-1.61M-1.39M2.90M-5.48M0.73M9.72M-11.85M3.19M3.97M11.30M-12.44M8.17M2.86M
Other Working Capital Changes (Quarter)
0.44M0.09M1.32M1.33M-0.18M1.18M0.41M0.34M2.23M1.12M-0.70M-0.23M-0.57M0.25M-1.13M2.71M1.90M7.74M11.13M0.10M
Investing Activities
Capital Expenditures (Quarter)
8.09M-3.23M47.98M40.64M16.46M11.82M-10.08M23.64M2.39M-0.30M0.35M3.02M-3.50M2.27M-0.94M-0.73M0.96M1.18M4.36M9.76M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
8.16M
Change in Acquisitions & Divestments (Quarter)
32.00M12.00M18.68M44.80M25.00M27.50M78.00M31.00M18.24M24.00M6.00M2.00M21.91M21.32M7.65M21.16M20.55M5.00M12.80M
Cash from Investing Activities (Quarter)
23.91M-226.58M-13.29M4.16M2.78M-6.97M41.16M18.67M-2.25M4.17M-5.24M-0.71M-1.28M-1.54M-1.43M-9.40M-12.40M-9.93M-12.71M-10.20M
Financing Activities
Other financing activities (Quarter)
-309.30M3.10M266.71M0.01M-263.81M0.60M0.25M0.35M0.17M0.95M1.32M2.92M1.92M2.95M0.77M1.83M3.79M0.30M1.79M3.79M
Cash from Financing Activities (Quarter)
1.57M-1.01M271.62M-1.31M1.24M-0.40M1.52M-0.66M0.44M-1.47M1.83M2.91M3.63M17.94M3.20M1.83M5.57M0.30M4.14M3.79M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)
-0.13M0.08M0.02M-0.10M-0.32M0.27M0.07M-0.32M-0.05M0.12M-0.07M0.00M0.07M-0.05M0.10M-0.07M0.16M0.01M-0.01M0.01M
Change in Cash (Quarter)
-9.45M-274.16M216.00M-31.38M2.44M-61.17M-1.53M-5.72M-22.56M-20.16M-22.90M-4.18M-12.90M-5.07M-11.11M-9.04M-18.48M-34.44M-26.13M-5.29M
Free Cash Flow (Quarter)
-42.89M-43.42M-90.32M-74.77M-17.73M-65.89M-34.21M-47.05M-23.10M-22.67M-19.77M-9.40M-11.81M-23.70M-12.05M-0.67M-12.78M-26.00M-21.92M-8.65M
Net Cash Flow (Quarter)
-9.32M-274.25M215.98M-31.27M2.76M-61.44M-1.60M-5.40M-22.51M-20.28M-22.84M-4.18M-12.98M-5.02M-11.22M-8.97M-18.64M-34.45M-26.13M-5.30M